Health Care: Drugs

Redhill Biopharma Ltd (RDHL: NASDAQ)

$9.76 0.39 | 4.16%
07/24/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 9.76
52 Week High 16.54
52 Week Low 8.16
Avg. Daily Vol. (Mil) 0.07
Beta (3 year) -0.60
Share Related Items
Mkt Cap (Mil) 166.49
Shares Out (Mil) 17.06
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.80
Current Ratio 10.90
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 1.65K
Price/Book 2.82
Price/Cash Flow -5.10
Per Share Data
Earnings -2.50
Sales 0.01
Book Value 3.46
Cash Flow -1.90
Business Summary
RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.
General Information
21 Ha'arba'a Street
Tel Aviv, 64739
Industry : Drugs
Sector: Health Care
Employees: 13
CEO: Mr. Dror Ben-Asher
Short Interest
Current Month (Mil) 0.17
Previous Month (Mil) 0.18
Short Interest Ratio (Days) 1.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -46.60
Return on Investments -55.00
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with RDHL

  • Portfolio NameUser Type

Latest RDHL Headlines from TheStreet

More Financial News for RDHL

Press Releases for RDHL

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter